
Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
In the latest episode of The HemOnc Pulse, Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, a lymphoma specialist at Oxford Cancer and Haematology Centre, discusses the findings from the HoLISTIC Consortium, and what he thinks about checkpoint inhibitors upfront in the treatment of Hodgkin lymphoma.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.